Valeant Vilified Over 'Death' Drug; Fund Managers Vexed
This article was originally published in Scrip
Executive Summary
There's hardly a day that goes by anymore without more fallout from the recent blowup of Valeant Pharmaceuticals International Inc., which has become the "poster child" of how not to run a drug company.